Basiliximab in association with tacrolimus and steroids in caucasian cadaveric renal transplanted patients: significant decrease in early acute rejection rate and hospitalization time-Reference-Cited by-同舟云学术

Basiliximab in association with tacrolimus and steroids in caucasian cadaveric renal transplanted patients: significant decrease in early acute rejection rate and hospitalization time

Published:2004-04 Issue:2 Volume:18 Page:113-118
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Leonardi Gianluca,Messina Maria,Giraudi Roberta,Pellu Valentina,Fop Fabrizio,Segoloni Giuseppe Paolo

Publisher

Wiley

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1399-0012.2003.00150.x/fullpdf

Reference34 articles.

1. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

2. REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

3. Screening for basiliximab exposure-response relationships in renal allotransplantation

4. Basiliximab

5. REDUCED ACUTE REJECTION AND SUPERIOR 1-YEAR RENAL ALLOGRAFT SURVIVAL WITH BASILIXIMAB IN PATIENTS WITH DIABETES MELLITUS1

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of tacrolimus with a cyclosporine microemulsion for immunosuppressive therapy in kidney transplantation;Türk Üroloji Dergisi/Turkish Journal of Urology;2013-08-06

2. Induction treatment with monoclonal antibodies for heart transplantation;Transplantation Reviews;2011-01

3. Hospitalization Databases: A Tool for Transplantation Monitoring;Transplantation Proceedings;2007-05

4. Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review;Clinical Transplantation;2005-07-26

5. Efficacy and safety of basiliximab in kidney transplantation;Expert Opinion on Drug Safety;2005-05